0001062993-19-002408.txt : 20190524 0001062993-19-002408.hdr.sgml : 20190524 20190524192305 ACCESSION NUMBER: 0001062993-19-002408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190522 FILED AS OF DATE: 20190524 DATE AS OF CHANGE: 20190524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattila Jyrki CENTRAL INDEX KEY: 0001297318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 19855704 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 40 VALLEY STREAM PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2019-05-22 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001297318 Mattila Jyrki C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2019-05-22 4 M 0 15000 37.64 A 15376 D Common Stock, $0.001 par value 2019-05-22 4 M 0 3750 41.82 A 19126 D Common Stock, $0.001 par value 2019-05-22 4 S 0 18750 62.06 D 376 D Stock Option (right to buy) 37.64 2019-05-22 4 M 0 15000 0 D 2025-04-22 Common Stock 15000 0 D Stock Option (right to buy) 41.82 2019-05-22 4 M 0 3750 0 D 2028-03-15 Common Stock 3750 11250 D The options were granted on April 22, 2015 and vested in four equal annual installments beginning on the first anniversary of the grant date. The options were granted on March 15, 2018, and vest in four equal annual installments beginning on the first anniversary of the grant date. /s/Jyrki Mattila, by Carl A. Valenstein, attorney-in-fact 2019-05-24